166 related articles for article (PubMed ID: 37017868)
1. Hospital antibiotic consumption-an interrupted time series analysis of the early and late phases of the COVID-19 pandemic in Poland, a retrospective study.
Siewierska M; Gajda M; Opalska A; Brudło M; Krzyściak P; Gryglewska B; Różańska A; Wójkowska-Mach J
Pharmacol Rep; 2023 Jun; 75(3):715-725. PubMed ID: 37017868
[TBL] [Abstract][Full Text] [Related]
2. The impact of the COVID-19 pandemic on healthcare-associated infections in intensive care unit patients: a retrospective cohort study.
Baccolini V; Migliara G; Isonne C; Dorelli B; Barone LC; Giannini D; Marotta D; Marte M; Mazzalai E; Alessandri F; Pugliese F; Ceccarelli G; De Vito C; Marzuillo C; De Giusti M; Villari P
Antimicrob Resist Infect Control; 2021 Jun; 10(1):87. PubMed ID: 34088341
[TBL] [Abstract][Full Text] [Related]
3. Antibiotic use during the first 6 months of COVID-19 pandemic in Iran: A large-scale multi-centre study.
Salehi M; Khalili H; Seifi A; Davoudi H; Darazam IA; Jahangard-Rafsanjani Z; Mohammadnejad E; Heydari B; Siahkaly SJM; Tabarsi P; Kalantari S; Menshadi SAD; Babamahmoodi F; Khorvash F; Davarpanah MA; Soltani R; Yaghoobi MH; Anari SAM; Khodadadi J; Aliramezani A; Hantooshzadeh S; Naderi HR; Hajiabdolbaghi M; Elyasi S; Firouzabadi D; Kasgari HA; Roshanzamiri S; Ebrahimpour S
J Clin Pharm Ther; 2022 Dec; 47(12):2140-2151. PubMed ID: 36054303
[TBL] [Abstract][Full Text] [Related]
4. Characteristics of Microbial Factors of Healthcare-Associated Infections Including Multidrug-Resistant Pathogens and Antibiotic Consumption at the University Intensive Care Unit in Poland in the Years 2011-2018.
Litwin A; Fedorowicz O; Duszynska W
Int J Environ Res Public Health; 2020 Sep; 17(19):. PubMed ID: 32977435
[No Abstract] [Full Text] [Related]
5. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
6. Few bacterial co-infections but frequent empiric antibiotic use in the early phase of hospitalized patients with COVID-19: results from a multicentre retrospective cohort study in The Netherlands.
Karami Z; Knoop BT; Dofferhoff ASM; Blaauw MJT; Janssen NA; van Apeldoorn M; Kerckhoffs APM; van de Maat JS; Hoogerwerf JJ; Ten Oever J
Infect Dis (Lond); 2021 Feb; 53(2):102-110. PubMed ID: 33103530
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of bacterial agents isolated from endotracheal aspirate cultures of Covid-19 general intensive care patients and their antibiotic resistance profiles compared to pre-pandemic conditions.
Bahçe YG; Acer Ö; Özüdoğru O
Microb Pathog; 2022 Mar; 164():105409. PubMed ID: 35041973
[TBL] [Abstract][Full Text] [Related]
8. Secondary Bacterial Infection and Clinical Characteristics in Patients With COVID-19 Admitted to Two Intensive Care Units of an Academic Hospital in Iran During the First Wave of the Pandemic.
Pourajam S; Kalantari E; Talebzadeh H; Mellali H; Sami R; Soltaninejad F; Amra B; Sajadi M; Alenaseri M; Kalantari F; Solgi H
Front Cell Infect Microbiol; 2022; 12():784130. PubMed ID: 35281440
[TBL] [Abstract][Full Text] [Related]
9. Bacterial infections and antibiotic utilization varies by coronavirus disease 19 (COVID-19) severity in hospitalized cancer patients: Analysis from the first phase of the pandemic.
Maki KR; Steiger SN; Su Y; Boumiza A; Tan CA; Kerpelev M; Seo SK; Cohen N
Infect Control Hosp Epidemiol; 2023 Mar; 44(3):413-419. PubMed ID: 35616016
[TBL] [Abstract][Full Text] [Related]
10. Antibiotic use in township hospitals during the COVID-19 pandemic in Shandong, China.
Wang T; Shen L; Yin J; Zhou L; Sun Q
Antimicrob Resist Infect Control; 2022 Dec; 11(1):164. PubMed ID: 36566210
[TBL] [Abstract][Full Text] [Related]
11. Impact of introducing procalcitonin testing on antibiotic usage in acute NHS hospitals during the first wave of COVID-19 in the UK: a controlled interrupted time series analysis of organization-level data.
Llewelyn MJ; Grozeva D; Howard P; Euden J; Gerver SM; Hope R; Heginbothom M; Powell N; Richman C; Shaw D; Thomas-Jones E; West RM; Carrol ED; Pallmann P; Sandoe JAT
J Antimicrob Chemother; 2022 Mar; 77(4):1189-1196. PubMed ID: 35137110
[TBL] [Abstract][Full Text] [Related]
12. Bacterial and fungal co-infections among ICU COVID-19 hospitalized patients in a Palestinian hospital: a retrospective cross-sectional study.
Naseef HA; Mohammad U; Al-Shami N; Sahoury Y; Abukhalil AD; Dreidi M; Alsahouri I; Farraj M
F1000Res; 2022; 11():30. PubMed ID: 35811795
[No Abstract] [Full Text] [Related]
13. Clinical characteristics of COVID-19 in 104 people with SARS-CoV-2 infection on the Diamond Princess cruise ship: a retrospective analysis.
Tabata S; Imai K; Kawano S; Ikeda M; Kodama T; Miyoshi K; Obinata H; Mimura S; Kodera T; Kitagaki M; Sato M; Suzuki S; Ito T; Uwabe Y; Tamura K
Lancet Infect Dis; 2020 Sep; 20(9):1043-1050. PubMed ID: 32539988
[TBL] [Abstract][Full Text] [Related]
14. Intensive Care Unit Admissions During the First 3 Months of the COVID-19 Pandemic in Poland: A Single-Center, Cross-Sectional Study.
Kokoszka-Bargieł I; Cyprys P; Rutkowska K; Madowicz J; Knapik P
Med Sci Monit; 2020 Sep; 26():e926974. PubMed ID: 32979262
[TBL] [Abstract][Full Text] [Related]
15. Reduction in antimicrobial use associated with a multifaceted antimicrobial stewardship programme in a tertiary teaching hospital in Shanghai: a segmented regression analysis.
Liu YX; Liang C; Yang Y; Le KJ; Zhang ZL; Gu ZC; Zhong H; Lin HW; Luo HJ
Ann Palliat Med; 2021 Jul; 10(7):7360-7369. PubMed ID: 34353033
[TBL] [Abstract][Full Text] [Related]
16. Intensive care for seriously ill patients affected by novel coronavirus sars - CoV - 2: Experience of the Crema Hospital, Italy.
Zuccon W; Comassi P; Adriani L; Bergamaschini G; Bertin E; Borromeo R; Corti S; De Petri F; Dolci F; Galmozzi A; Gigliotti A; Gualdoni L; Guerra C; Khosthiova A; Leati G; Lupi G; Moscato P; Perotti V; Piantelli M; Ruini A; Sportelli S; Susca M; Troiano C; Benelli G; Buscarini E; Canetta C; Merli G; Scartabellati A; Melilli B S C G; Sfogliarini R; Pellegatta G; Viganò G
Am J Emerg Med; 2021 Jul; 45():156-161. PubMed ID: 33046317
[TBL] [Abstract][Full Text] [Related]
17. Assessment of Referrals and Hospitalizations in the Hospital Transformed into COVID-19 Facility in Poland during the "Spring Wave" of the Epidemic in 2020-A Cross-Sectional Study.
Kasiukiewicz A; Wojszel ZB
Int J Environ Res Public Health; 2021 Jul; 18(13):. PubMed ID: 34281079
[TBL] [Abstract][Full Text] [Related]
18. Antimicrobial stewardship in the UK during the COVID-19 pandemic: a population-based cohort study and interrupted time-series analysis.
Rezel-Potts E; L'Esperance V; Gulliford MC
Br J Gen Pract; 2021 May; 71(706):e331-e338. PubMed ID: 33690150
[TBL] [Abstract][Full Text] [Related]
19. Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy.
Grasselli G; Zangrillo A; Zanella A; Antonelli M; Cabrini L; Castelli A; Cereda D; Coluccello A; Foti G; Fumagalli R; Iotti G; Latronico N; Lorini L; Merler S; Natalini G; Piatti A; Ranieri MV; Scandroglio AM; Storti E; Cecconi M; Pesenti A;
JAMA; 2020 Apr; 323(16):1574-1581. PubMed ID: 32250385
[TBL] [Abstract][Full Text] [Related]
20. The interface between COVID-19 and bacterial healthcare-associated infections.
O'Toole RF
Clin Microbiol Infect; 2021 Dec; 27(12):1772-1776. PubMed ID: 34111586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
